← Leaderboards
Sumner H Burstein
Univ Of Massachusetts Med Sch Worcester
$1,791,353
Attributed
$1,791,353
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $339.8K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,791,353 · 3
By mechanism
R01$1,400,547 · 2
R21$390,806 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Robert B Zurier$5,188,602
- Stephen C. Miller$9,374,213
- Hardy Kornfeld$32,043,759
- Amit Singhal$3,635,183
Others in their field
Top investigators on “Cannabinoids”
- Alexandros Makriyannis · University Of Connecticut Storrs$39,379,878
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$31,535,958
- Deepak Cyril D'souza · Va Connecticut Healthcare System$18,310,025
- Daniele Piomelli · University Of California Irvine$17,726,721
- Kenneth P. Mackie · Queen'S Medical Center$16,568,516
- Jenny L. Wiley · Virginia Commonwealth University$14,895,613
Research focus
CannabinoidsDrug Screening /EvaluationAnalgesicsCannabinoid ReceptorAnandamideAnalogAntiinflammatory AgentsInhibitor/AntagonistGlycineInterestAbsence Of Pain SensationFamilyHuman TissueEndocannabinoidsAnti-InflammatoryEnzymesBiologicalBinding SitesAcidsAnti-Inflammatory AgentsChemical Structure FunctionExposure ToBaseIn Vivo
Grant awards (9)
The elmiric acids: biologically active anandamide analogs.$324,341
R01 · FY2010 · DA · contact PI
The elmiric acids: biologically active anandamide analogs.$339,814
R01 · FY2009 · DA · contact PI
Endocannabinoid Analogs as Anti-inflammatory Agents$29,160
R21 · FY2008 · DA · contact PI
Endocannabinoid Analogs as Anti-inflammatory Agents$118,646
R21 · FY2006 · DA · contact PI
Endocannabinoid Analogs as Anti-inflammatory Agents$121,500
R21 · FY2005 · DA
Endocannabinoid Analogs as Anti-inflammatory Agents$121,500
R21 · FY2004 · DA
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL$251,991
R01 · FY2002 · DA
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL$245,780
R01 · FY2001 · DA
NON PSYCHOACTIVE CANNABINOIDS WITH THERAPEUTIC POTENTIAL$238,621
R01 · FY2000 · DA